Orchestra BioMed Holdings, Inc. (OBIO) earnings
Quarterly results of Orchestra BioMed Holdings, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Orchestra BioMed Holdings, Inc. was expected to report around November 9, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Orchestra BioMed Holdings, Inc. reported revenue of $88K (-89.5% on the same quarter a year earlier) and a net loss of $23.8M.
Diluted earnings per share were -$0.38.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $88K | -89.5% | -$23.8M | -$0.38 |
| Q1 FY2026 | $110K | -87.3% | -$20.7M | -$0.33 |
| Q4 FY2025 | $30.9M | +12,120.2% | $6.2M | - |
| Q3 FY2025 | $861K | -12.8% | -$20.8M | -$0.40 |
| Q2 FY2025 | $836K | - | -$19.4M | -$0.50 |
| Q1 FY2025 | $868K | - | -$18.8M | -$0.49 |
| Q4 FY2024 | $253K | - | -$16.2M | - |
| Q3 FY2024 | $987K | - | -$15.4M | -$0.41 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Annual report 10-K
When is Orchestra BioMed Holdings, Inc.'s next earnings date?
Orchestra BioMed Holdings, Inc. was expected to report around November 9, 2026; nothing is on file with the SEC yet.
What were Orchestra BioMed Holdings, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Orchestra BioMed Holdings, Inc. reported revenue of $88K and a net loss of $23.8M. The figures come from its filing with the SEC.
Is Orchestra BioMed Holdings, Inc.'s revenue growing?
Revenue in Q2 FY2026 was $88K, down 89.5% from $836K in the same quarter a year earlier.
Get an email when OBIO reports
Follow OBIO and we email you its next results the day they are filed, with the numbers explained.